Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1974 Nov;54(5):1064–1073. doi: 10.1172/JCI107850

Studies on “Big” Growth Hormone from Human Plasma and Pituitary

Donald R Wright 1, A David Goodman 1, Kathleen D Trimble 1
PMCID: PMC301654  PMID: 4421152

Abstract

Most of the immunoreactive growth hormone (IRGH) in human plasma elutes from Sephadex G-75 as “little” GH (LGH), mol wt 22,000, but 14-39% elutes earlier (“big” GH, BGH). In saline extracts of human pituitary, 11-17% of IRGH eluted as BGH. On gel filtration of pituitary and plasma BGH in 8 M urea, 59-81% ran as LGH, but when the remaining BGH was refiltered in urea, all ran as BGH. Thus there is a “urea-stable” and a “urea-labile” form of BGH. SImilarly, freezing and thawing converted over half of pituitary and plasma BGH to LGH, but when the “freeze-stable” BGH was again frozen, thawed, and refiltered, almost all ran as BGH. Urea-stable BGH was not dissociated by freezing, and most of the freeze-stable BGH was stable in urea, so the two forms are very similar or identical. Since 8 M urea and freezing dissociate peptides linked by noncovalent bonds, probably the BGH that is dissociated by urea and freezing consists of LGH bound noncovalently to another moiety, while in stable BGH the LGH is bound to another molecule by covalent or unusually strong noncovalent linkage. On centrifugation, the sedimentation of urea-stable BGH was consistent with a mol wt about twice that of LGH. Trypsinization of urea-stable BGH converted 36-59% to LGH, suggesting that some BGH may be a “prohormone” of LGH. On retrypsinization of the BGH that was not converted to LGH, only 13-24% converted, suggesting that there may be two forms of urea-stable BGH which vary in their response to trypsin.

Full text

PDF
1064

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bala R. M., Ferguson K. A., Beck J. C. Plasma biological and immunoreactive human growth hormone-like activity. Endocrinology. 1970 Sep;87(3):506–516. doi: 10.1210/endo-87-3-506. [DOI] [PubMed] [Google Scholar]
  2. Frohman L. A., Burek L., Stachura M. A. Characterization of growth hormone of different molecular weights in rat, dog and human pituitaries. Endocrinology. 1972 Jul;91(1):262–269. doi: 10.1210/endo-91-1-262. [DOI] [PubMed] [Google Scholar]
  3. Frohman L. A., Stachura M. E. Evidence for possible precursors in the synthesis of growth hormone by rat and human fetal anterior pituitary in vitro. Mt Sinai J Med. 1973 May-Jun;40(3):414–421. [PubMed] [Google Scholar]
  4. Goodman A. D., Tanenbaum R., Rabinowitz D. Existence of two forms of immunoreactive growth hormone in human plasma. J Clin Endocrinol Metab. 1972 Dec;35(6):868–878. doi: 10.1210/jcem-35-6-868. [DOI] [PubMed] [Google Scholar]
  5. Gorden P., Hendricks C. M., Roth J. Evidence for "big" and "little" components of human plasma and pituitary growth hormone. J Clin Endocrinol Metab. 1973 Jan;36(1):178–184. doi: 10.1210/jcem-36-1-178. [DOI] [PubMed] [Google Scholar]
  6. Gorden P., Lesniak M. A., Hendricks C. M., Roth J. "Big" growth hormone components from human plasma: decreased reactivity demonstrated by radioreceptor assay. Science. 1973 Nov 23;182(4114):829–831. doi: 10.1126/science.182.4114.829. [DOI] [PubMed] [Google Scholar]
  7. HUNTER W. M., GREENWOOD F. C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962 May 5;194:495–496. doi: 10.1038/194495a0. [DOI] [PubMed] [Google Scholar]
  8. KAUZMANN W. Some factors in the interpretation of protein denaturation. Adv Protein Chem. 1959;14:1–63. doi: 10.1016/s0065-3233(08)60608-7. [DOI] [PubMed] [Google Scholar]
  9. LI C. H., LIU W. K., DIXON J. S. Human pituitary growth hormone. VI. Modified procedure of isolation and NH2-terminal amino acid sequence. Arch Biochem Biophys. 1962 Sep;Suppl 1:327–332. [PubMed] [Google Scholar]
  10. MARTIN R. G., AMES B. N. A method for determining the sedimentation behavior of enzymes: application to protein mixtures. J Biol Chem. 1961 May;236:1372–1379. [PubMed] [Google Scholar]
  11. Olesen H., Pedersen P. O. Gel filtration of albumin on sephadex g-200 in urea. Acta Chem Scand. 1968;22(5):1386–1394. doi: 10.3891/acta.chem.scand.22-1386. [DOI] [PubMed] [Google Scholar]
  12. Pierce J. G. Eli Lilly lecture. The subunits of pituitary thyrotropin--their relationship to other glycoprotein hormones. Endocrinology. 1971 Dec;89(6):1331–1344. doi: 10.1210/endo-89-6-1331. [DOI] [PubMed] [Google Scholar]
  13. Shiu R. P., Kelly P. A., Friesen H. G. Radioreceptor assay for prolactin and other lactogenic hormones. Science. 1973 Jun 1;180(4089):968–971. doi: 10.1126/science.180.4089.968. [DOI] [PubMed] [Google Scholar]
  14. Steiner D. F., Oyer P. E. The biosynthesis of insulin and a probable precursor of insulin by a human islet cell adenoma. Proc Natl Acad Sci U S A. 1967 Feb;57(2):473–480. doi: 10.1073/pnas.57.2.473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Tsushima T., Friesen H. G. Radioreceptor assay for growth hormone. J Clin Endocrinol Metab. 1973 Aug;37(2):334–337. doi: 10.1210/jcem-37-2-334. [DOI] [PubMed] [Google Scholar]
  16. Yalow R. S., Berson S. A. Characteristics of "big ACTH" in human plasma and pituitary extracts. J Clin Endocrinol Metab. 1973 Mar;36(3):415–423. doi: 10.1210/jcem-36-3-415. [DOI] [PubMed] [Google Scholar]
  17. Yalow R. S., Berson S. A. Further studies on the nature of immunoreactive gastrin in human plasma. Gastroenterology. 1971 Feb;60(2):203–214. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES